Oramed Pharmaceuticals Inc. (ORMP): Price and Financial Metrics

Oramed Pharmaceuticals Inc. (ORMP): $2.20

0.13 (-5.58%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add ORMP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#62 of 362

in industry

ORMP Price/Volume Stats

Current price $2.20 52-week high $5.25
Prev. close $2.33 52-week low $1.67
Day low $2.14 Volume 240,800
Day high $2.37 Avg. volume 172,116
50-day MA $2.91 Dividend yield N/A
200-day MA $2.68 Market Cap 89.14M

ORMP Stock Price Chart Interactive Chart >


Oramed Pharmaceuticals Inc. (ORMP) Company Bio


Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company was founded in 2002 and is based in Jerusalem, Israel.


ORMP Latest News Stream


Event/Time News Detail
Loading, please wait...

ORMP Latest Social Stream


Loading social stream, please wait...

View Full ORMP Social Stream

Latest ORMP News From Around the Web

Below are the latest news stories about ORAMED PHARMACEUTICALS INC that investors may wish to consider to help them evaluate ORMP as an investment opportunity.

Oramed Pharmaceuticals (NASDAQ:ORMP) investors are sitting on a loss of 63% if they invested a year ago

Investing in stocks comes with the risk that the share price will fall. And there's no doubt that Oramed...

Yahoo | October 6, 2023

ORMP: Distribution Deals, JVs in Anticipation of Commercializing ORMD-0801

By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT JV with HTIT to help commercialize ORMD–0801 … Oramed Pharmaceuticals (NASDAQ:ORMP) continues to advance its proprietary oral protein delivery platform and is researching the technology potentially to treat diabetes, NASH (nonalcoholic steatohepatitis (NASH), and obesity, as an appetite suppressant, and a COVID vaccine, among other

Yahoo | October 5, 2023

Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company

Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento" or "Company"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, announced the consummation on September 21, 2023, of the previously announced sale to Scilex Holding Company (Nasdaq: SCLX, "Scilex") of certain securities that Sorrento held in Scilex.

Yahoo | September 22, 2023

Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE:ORMP) today announced that on September 21, 2023, Oramed and Scilex Holding Company ("Scilex") entered into a Securities Purchase Agreement pursuant to which Scilex issued a Senior Secured Promissory Note (the "Note") to Oramed. The Note is the culmination of Scilex's assumption of Sorrento Therapeutics Inc.'s ("Sorrento") approximately $100 million senior secured Debtor In Possession ("DIP") term loan facility with Oramed. Oramed previously annou

Yahoo | September 21, 2023

Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.

PALO ALTO, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, announced the consummation of the previously announced purchase of securities from Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”). Pursuant to that certain Stock Purchase Agreement entered into on Septem

Yahoo | September 21, 2023

Read More 'ORMP' Stories Here

ORMP Price Returns

1-mo -25.68%
3-mo -1.12%
6-mo 7.32%
1-year -3.51%
3-year -73.62%
5-year -45.41%
YTD -4.76%
2023 -80.80%
2022 -15.76%
2021 236.79%
2020 -17.67%
2019 71.67%

Continue Researching ORMP

Want to see what other sources are saying about Oramed Pharmaceuticals Inc's financials and stock price? Try the links below:

Oramed Pharmaceuticals Inc (ORMP) Stock Price | Nasdaq
Oramed Pharmaceuticals Inc (ORMP) Stock Quote, History and News - Yahoo Finance
Oramed Pharmaceuticals Inc (ORMP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!